Arkolith/Insider Trading/ERNA/Form 4

Gurrola Sandra M

Vice President of FinanceEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Jun 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2023Tax withholding(F)179$2.48$444928
Jun 21, 2023Option exercise(M)438——1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 21, 2023Option exercise(M)438—$0874

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-031258) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML